The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial Cells
Open accessAbstract
Docosahexaenoic acid (DHA, C22:6) is highly enriched in brain, synapses, and retina and is a major omega-3 fatty acid. Deficiencies in this essential fatty acid are reportedly associated with neuronal function, cancer, and inflammation. Here, using new lipidomic analyses employing high performance liquid chromatography coupled with a photodiode-array detector and a tandem mass spectrometer, a novel series of endogenous mediators was identified in blood, leukocytes, brain, and glial cells as 17S-hydroxy-containing docosanoids denoted as docosatrienes (the main bioactive member of the series was 10,17S-docosatriene) and 17S series resolvins. These novel mediators were biosynthesized via epoxide-containing intermediates and proved potent (pico- to nanomolar range) regulators of both leukocytes reducing infiltration in vivo and glial cells blocking their cytokine production. These results indicate that DHA is the precursor to potent protective mediators generated via enzymatic oxygenations to novel docosatrienes and 17S series resolvins that each regulate events of interest in inflammation and resolution.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






![FIG. 3 Human glial cells release and transform DHA. A , human glial cells were labeled with [1- 14 C]DHA and exposed to either PBS alone, zymosan A, or calcium ionophore (see 'Experimental Procedures'). Released [114 C]docosanoids were quantified ( n = 4). The asterisk denotes significant differences from control (PBS alone), p < 0.05 analysis of variance, Newman-Keuls test. The inset shows a representative HPLC radiochromatogram of released [1- 14 C]docosanoids (see 'Experimental Procedures') from glial cells exposed to zymosan A ( n = 3). Phospholipids from glial cells were identified, and the 14 C content in phosphatidylethanolamine ( PE ) was determined. The percent loss in PE 14 C content from cells exposed to agonists was determined ( n = 2). B , lipidomic profile of human glial cells exposed to Ca 2 + ionophore: LC-MS total ion chromatogram of released products. C , LC-MS selective ion chromatogram of released DHA-derived products from glial cells exposed to calcium ionophore. MS-MS and UV spectra of 𝛚 -22hydroxy-4 S ,17 S -diHDHA.](https://figures.cochat.ai/paper-figures/3022e35eb41542a6a28d8ac7db63b15b/novel-docosatrienes-and-17s-resolvins-generated-from-docosahexaenoic-acid-in-figure-3.png)



![FIG. 5 Substrate competition at human recombinant COX-2. Human rCOX-2 microsomal membranes from Sf9 cells were incubated with [1- 14 C]DHA (C22:6, 10 𝛍 M) in the presence of increasing concentrations of unlabeled arachidonic acid (C20:4). COX-2 conversion of [1- 14 C]DHA and specific product profiles were quantitated ( n = 3). rCOX-2 activity is expressed as the inhibition of [ 14 C]C22:6 product formation (95 ± 0.5%; conversion of DHA was set to 100%).](https://figures.cochat.ai/paper-figures/b879709650c441a69692ab58e3270712/novel-docosatrienes-and-17s-resolvins-generated-from-docosahexaenoic-acid-in-figure-5.png)





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Prostaglandin E2 (PGE2) and D2 rapidly initiate the resolution process by inducing the expression of lipid mediators with both anti-inflammatory and pre-resolution functions, e.g., lipoxins [96, 97], resolvins and protectins [98–100], a process known as lipid-mediator class switch [97].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [98]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects
Samuelsson, B., Dahlén, S.-E., Lindgren, J. Å., Rouzer, C. A., & Serhan, C. N. (1987) · Science · doi:10.1126/science.2820055 · Cited by 2,233
Self-citationSerhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650
Self-citationLipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453
Self-citationMarchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M. G., Geraci, E., Levantesi, G., Maggioni, A. P., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014682.14181.f2 · Cited by 1,311
Serhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., & Gronert, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1197 · Cited by 1,189
Self-citationA NEW DEFICIENCY DISEASE PRODUCED BY THE RIGID EXCLUSION OF FAT FROM THE DIET
Burr, G. O., & Burr, M. M. (1929) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)78281-5 · Cited by 1,185
Gunstone, F. D., Harwood, J. L., & Padley, F. B. (1994) · Cited by 1,010
Mechanisms of action of docosahexaenoic acid in the nervous system
Salem, N., Litman, B., Kim, H., & Gawrisch, K. (2001) · Lipids · doi:10.1007/s11745-001-0805-6 · Cited by 919
Fish consumption and major depression
Hibbeln, J. R. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79168-6 · Cited by 896
Research works printed but not linked: 3
- Gronert, 1998, J. Pharmacol. Exp. Ther., 285, 252
- Whelan, 1990, 2, 765
- Bazan, 1990, 8, 1
Cited by
Pro-resolving lipid mediators are leads for resolution physiology
Serhan, C. N. (2014) · Nature · doi:10.1038/nature13479 · Cited by 3,041
Self-citationResolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Serhan, C. N., Chiang, N., & Van Dyke, T. E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2294 · Cited by 2,932
“Unexpectedly, two of these recently described lipid mediator families, the resolvins and protectins, are biosynthesized from precursor essential omega-3 polyunsaturated fatty acids (PUFAs), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA”
BackgroundSelf-citationResolution of inflammation: the beginning programs the end
Serhan, C. N., & Savill, J. (2005) · Nature Immunology · doi:10.1038/ni1276 · Cited by 2,552
“, as well as newly identified families of lipid mediators generated from omega-3 polyunsaturated fatty acid called resolvins (resolution-phase interaction products) and protectin”
Self-citationn−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
Calder, P. C. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1505s · Cited by 2,525
Transition from inflammation to proliferation: a critical step during wound healing
Landén, N. X., Li, D., & Ståhle, M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2268-0 · Cited by 1,980
Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance
Calder, P. C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.010 · Cited by 1,717
Polyunsaturated fatty acids and their metabolites in brain function and disease
Bazinet, R. P., & Layé, S. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3820 · Cited by 1,605
Omega-3 fatty acids and inflammatory processes: from molecules to man
Calder, P. C. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160474 · Cited by 1,456
Omega‐3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?
Calder, P. C. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04374.x · Cited by 1,347
Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
Serhan, C. N., & Levy, B. D. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97943 · Cited by 1,344
“Microglial cell production of proinflammatory cytokines is selectively reduced by SPMs (23, 24), with increased production of antiinflammatory IL-10 (130).”
BackgroundSelf-citationThe Opposing Effects of N-3 and n-6 Fatty Acids
Schmitz, G., & Ecker, J. (2008) · Progress in Lipid Research · doi:10.1016/j.plipres.2007.12.004 · Cited by 1,245
Resolvin E1 and protectin D1 activate inflammation-resolution programmes
Schwab, J. M., Chiang, N., Arita, M., & Serhan, C. N. (2007) · Nature · doi:10.1038/nature05877 · Cited by 1,184
Self-citationInflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180
“These can influence cytokine synthesis and resolve inflammation (Hong et al., 2003, Serhan, 2010).”
BackgroundWall, R., Ross, R. P., Fitzgerald, G. F., & Stanton, C. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00287.x · Cited by 1,101
Emerging targets in neuroinflammation-driven chronic pain
Ji, R.-R., Xu, Z.-Z., & Gao, Y.-J. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4334 · Cited by 1,101
Serhan, C. N. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141647 · Cited by 997
Self-citationResolvins and protectins in inflammation resolution
Serhan, C. N., & Petasis, N. A. (2011) · Chemical Reviews · doi:10.1021/cr100396c · Cited by 996
Self-citationMaresins: Novel macrophage mediators with potent antiinflammatory and proresolving actions
Serhan, C. N., Yang, R., Martinod, K., Kasuga, K., Pillai, P. S., Porter, T. F., Oh, S. F., & Spite, M. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081880 · Cited by 908
Self-citationThe role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina
SanGiovanni, J. P., & Chew, E. Y. (2005) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2004.06.002 · Cited by 874
“, 2000) inhibitors and LOX metabolites (Hong et al., 2003; Serhan et al., 2000a, b; Serhan and Oliw, 2001).”
BackgroundLukiw, W. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25420 · Cited by 872
“PDA-ESI-MS-MS according to reported biophysical criteria (6, 49).”
BackgroundMethodInfluentialProresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation
Buckley, C. D., Gilroy, D. W., & Serhan, C. N. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.009 · Cited by 807
“bioactive products identified within the resolution phase of acute sterile inflammation (illustrated in top panel of Figure 1) that activate pro-resolving mechanisms (Hong et al., 2003; Serhan et al., 2000; Serhan et al., 2002).”
BackgroundInfluentialSelf-citationAdvances in Our Understanding of Oxylipins Derived from Dietary PUFAs
Gabbs, M., Leng, S., Devassy, J. G., Monirujjaman, M., & Aukema, H. M. (2015) · Advances in Nutrition · doi:10.3945/an.114.007732 · Cited by 798
“, aspirin-triggered protectin D1) (26, 97, 98).”
BackgroundInfluentialMarcheselli, V. L., Hong, S., Lukiw, W. J., Tian, X. H., Gronert, K., Musto, A., Hardy, M., Gimenez, J. M., Chiang, N., Serhan, C. N., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305841200 · Cited by 802
Self-citationSpecialized pro-resolving mediators: endogenous regulators of infection and inflammation
Basil, M. C., & Levy, B. D. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.4 · Cited by 791
Microglia in Pain: Detrimental and Protective Roles in Pathogenesis and Resolution of Pain
Chen, G., Zhang, Y.-Q., Qadri, Y. J., Serhan, C. N., & Ji, R.-R. (2018) · Neuron · doi:10.1016/j.neuron.2018.11.009 · Cited by 780
Self-citationInflammatory Resolution: new opportunities for drug discovery
Gilroy, D. W., Lawrence, T., Perretti, M., & Rossi, A. G. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1383 · Cited by 772
Mukherjee, P. K., Marcheselli, V. L., Serhan, C. N., & Bazan, N. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402531101 · Cited by 753
Self-citationPolyunsaturated fatty acids and inflammatory processes: New twists in an old tale
Calder, P. C. (2009) · Biochimie · doi:10.1016/j.biochi.2009.01.008 · Cited by 721
Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis
Spite, M., Norling, L. V., Summers, L., Yang, R., Cooper, D., Petasis, N. A., Flower, R. J., Perretti, M., & Serhan, C. N. (2009) · Nature · doi:10.1038/nature08541 · Cited by 695
Self-citationConnor, K. M., SanGiovanni, J. P., Lofqvist, C., Aderman, C. M., Chen, J., Higuchi, A., Hong, S., Pravda, E. A., Majchrzak, S., Carper, D., et al. (2007) · Nature Medicine · doi:10.1038/nm1591 · Cited by 688
Self-citationDyall, S. C., Balas, L., Bazan, N. G., Brenna, J. T., Chiang, N., da Costa Souza, F., Dalli, J., Durand, T., Galano, J.-M., Lein, P. J., et al. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101165 · Cited by 660
Self-citationThe role of neutrophils during intestinal inflammation
Fournier, B. M., & Parkos, C. A. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.24 · Cited by 671
Essential Fatty Acids: Biochemistry, Physiology and Pathology
Das, U. N. (2006) · Biotechnology Journal · doi:10.1002/biot.200600012 · Cited by 650
“Of the several 17-hydroxy-containing bioactive mediators derived from DHA, which were termed docosatrienes and 17S series resolvins, 10,17S-dihydroxydocosatriene, also called neuroprotectin D1 (NPD1), was found to reduce the infiltration of PMNs and possess potent anti-inflammatory and neuroprotective properties [92,…”
BackgroundPolyunsaturated fatty acids and inflammation
Calder, P. C. (2006) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2006.05.012 · Cited by 638
Resolution of Inflammation: What Controls Its Onset?
Sugimoto, M. A., Sousa, L. P., Pinho, V., Perretti, M., & Teixeira, M. M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00160 · Cited by 638
“Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-treated macrophages and annexin-derived peptide Ac(2-26).”
BackgroundMammalian lipoxygenases and their biological relevance
Kuhn, H., Banthiya, S., & van Leyen, K. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.10.002 · Cited by 624
Arachidonate 5-Lipoxygenase Promoter Genotype, Dietary Arachidonic Acid, and Atherosclerosis
Dwyer, J. H., Allayee, H., Dwyer, K. M., Fan, J., Wu, H., Mar, R., Lusis, A. J., & Mehrabian, M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa025079 · Cited by 619
The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution
Serhan, C. N., Chiang, N., & Dalli, J. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.03.004 · Cited by 583
Self-citationMolecular Circuits of Resolution: Formation and Actions of Resolvins and Protectins
Bannenberg, G. L., Chiang, N., Ariel, A., Arita, M., Tjonahen, E., Gotlinger, K. H., Hong, S., & Serhan, C. N. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.4345 · Cited by 699
“4 and 5D) (7, 9, 16), we sought to examine whether they can regulate cellular composition and molecular components involved in resolution of acute inflammation.”
BackgroundMethodSelf-citationMechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids
Adkins, Y., & Kelley, D. S. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.12.004 · Cited by 557
“Other potent oxygenated metabolites found during the resolution phase of inflammation are (1) resolvins E and D series that are formed from EPA and DHA, respectively, by aspirin-acetylated COX-2 in vascular endothelial cells and 5-LOX in leukocytes and (2) protectins formed from DHA by leukocytes and other cell types…”
BackgroundGonzález-Périz, A., Horrillo, R., Ferré, N., Gronert, K., Dong, B., Morán-Salvador, E., Titos, E., Martínez-Clemente, M., López-Parra, M., Arroyo, V., et al. (2009) · The FASEB Journal · doi:10.1096/fj.08-125674 · Cited by 555
“These novel oxygenated products originated from -3PUFAs evoke potent protective actions demonstrable at the nanomolar and picomolar ranges, many of which are related to the resolution of unremitting inflammation (12, 16-20, 36, 46-48).”
BackgroundSelf-citationSerhan, C. N. (2017) · The FASEB Journal · doi:10.1096/fj.201601222r · Cited by 555
Self-citationLipid Mediators in the Resolution of Inflammation
Serhan, C. N., Chiang, N., Dalli, J., & Levy, B. D. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016311 · Cited by 544
“1) that activate new proresolving mechanisms (Serhan et al. 2000, 2002; Hong et al. 2003).”
BackgroundMethodInfluentialSelf-citationMcNamara, R. K., & Carlson, S. E. (2006) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2006.07.010 · Cited by 545
“Once mobilized, DHA may act as a second messenger in the modulation of synaptic signal transduction pathways [27], is metabolized into anti-inflammatory docosanoids [28], is degraded by b-oxidation or peroxidation [29], or is reacylated into membrane phospholipids by aceyltransferases.”
BackgroundResolvin D1 and Its Aspirin-triggered 17R Epimer
Sun, Y.-P., Oh, S. F., Uddin, J., Yang, R., Gotlinger, K., Campbell, E., Colgan, S. P., Petasis, N. A., & Serhan, C. N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609212200 · Cited by 537
Self-citationInflammation and its Resolution as Determinants of Acute Coronary Syndromes
Libby, P., Tabas, I., Fredman, G., & Fisher, E. A. (2014) · Circulation Research · doi:10.1161/circresaha.114.302699 · Cited by 521
Anti-Inflammatory and Proresolving Lipid Mediators
Serhan, C. N., Yacoubian, S., & Yang, R. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.151409 · Cited by 507
Self-citationThe relationship between the fatty acid composition of immune cells and their function
Calder, P. C. (2008) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2008.09.016 · Cited by 499
“Resolvin synthesis is increased by feeding fish oil-rich diets to laboratory rodents [75] and was recently shown to occur in fat-1 mice in which colitis had been induced [65].”
BackgroundInflammation in cystic fibrosis lung disease: Pathogenesis and therapy
Cantin, A. M., Hartl, D., Konstan, M. W., & Chmiel, J. F. (2015) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2015.03.003 · Cited by 496
“DHA is a precursor of several anti-inflammatory lipids including the resolvins [36].”
BackgroundSerhan, C. N., Dalli, J., Colas, R. A., Winkler, J. W., & Chiang, N. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.006 · Cited by 492
“PD1 isolated and identified earlier carries alcohol groups at carbon 10 and 17 positions flanking its conjugated triene portion of this molecule, found to be critical for potent functions of this molecule [9,13].”
InfluentialSelf-citationNutritional Modulation of Immune Function: Analysis of Evidence, Mechanisms, and Clinical Relevance
Wu, D., Lewis, E. D., Pae, M., & Meydani, S. N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03160 · Cited by 481
Specialized pro-resolving lipid mediators in the inflammatory response: An update
Bannenberg, G., & Serhan, C. N. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.08.002 · Cited by 464
Self-citationModulation of inflammation in brain: A matter of fat
Farooqui, A. A., Horrocks, L. A., & Farooqui, T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04371.x · Cited by 460
“Thus, growing evidence suggests that the generation of n-3 fatty acid metabolites may be an internal anti-inflammatory protective mechanism for preventing brain damage in neural trauma and neurodegenerative diseases (Hong et al. 2003; Marcheselli et al. 2003; Mukherjee et al. 2004; Bazan 2005b; Serhan 2005b).”
BackgroundInfluentialHasturk, H., Kantarci, A., Goguet-Surmenian, E., Blackwood, A., Andry, C., Serhan, C. N., & Van Dyke, T. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.10.7021 · Cited by 461
“A rapidly emerging body of evidence demonstrates that endogenous mediators actively participate in dampening host responses to orchestrate resolution of inflammation (33, 34).”
BackgroundSelf-citationResolvins, Specialized Proresolving Lipid Mediators, and Their Potential Roles in Metabolic Diseases
Spite, M., Clària, J., & Serhan, C. N. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.10.006 · Cited by 464
“identified a novel genus of bioactivemediators that comprise four families of distinct structures, namely lipoxins, resolvins, protectins, and maresins, all of which are biosynthesizedwithin the resolutionphase of acute inflammation (Levy et al., 2001; Serhan et al., 2000, 2002; Hong et al., 2003).”
BackgroundSelf-citationPhillis, J. W., Horrocks, L. A., & Farooqui, A. A. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.02.002 · Cited by 459
Serhan, C. N., Gotlinger, K., Hong, S., Lu, Y., Siegelman, J., Baer, T., Yang, R., Colgan, S. P., & Petasis, N. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1848 · Cited by 455
“The main positional isomer of 10,17S-docosatriene was 7,17-diHDHA (denoted as resolvin D5), as documented earlier (1, 3), and a double dioxygenation product (37).”
BackgroundMethodResultInfluentialSelf-citationPolyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases
Calder, P. C. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700289 · Cited by 457
Serhan, C. N. (2005) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.002 · Cited by 454
Self-citationVery long-chain fatty acids: elongation, physiology and related disorders
Kihara, A. (2012) · Journal of Biochemistry · doi:10.1093/jb/mvs105 · Cited by 441
“Resolvin D exerts anti-inflammatory actions by reducing neutrophil migration and infiltration (31, 33).”
BackgroundSpecialized pro-resolving mediator network: an update on production and actions
Chiang, N., & Serhan, C. N. (2020) · Essays in Biochemistry · doi:10.1042/ebc20200018 · Cited by 438
Self-citationNeuronal Lipid Metabolism: Multiple Pathways Driving Functional Outcomes in Health and Disease
Tracey, T. J., Steyn, F. J., Wolvetang, E. J., & Ngo, S. T. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00010 · Cited by 433
Endogenous pro‐resolving and anti‐inflammatory lipid mediators: a new pharmacologic genus
Serhan, C. N., & Chiang, N. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707489 · Cited by 431
“…et al., 2004; Lukiw et al., 2005) have documented the formation of NPD1 in neural tissues and identified its potent immunomodulatory actions (Serhan et al., 2002, 2006a; Hong et al., 2003) and neuroprotective actions (Marcheselli et al., 2003; Mukherjee et al., 2004; Lukiw et al., 2005) (Table 5).”
BackgroundMethodInfluentialSelf-citationColas, R. A., Shinohara, M., Dalli, J., Chiang, N., & Serhan, C. N. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00024.2014 · Cited by 421
Self-citationNovel Lipid Mediators and Resolution Mechanisms in Acute Inflammation
Serhan, C. N. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100322 · Cited by 421
“Additionally, exudates obtained from mice given DHA, after extraction and transfer to other mice with peritonitis, reduced neutrophil infiltration in vivo, indicating the presence of potent bioactive products within the original inflammatory exudates.(9,20) In parallel, experiments with isolated human cells were carri…”
BackgroundInfluentialSelf-citationLayé, S., Nadjar, A., Joffre, C., & Bazinet, R. P. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014092 · Cited by 420
“NPD1 protects the brain toward leukocyte infiltration, COX-2 expression, cytokine production, and microglia activation (Hong et al., 2003; Marcheselli et al., 2003, 2010; Lukiw et al., 2005; Orr et al., 2013).”
BackgroundTitos, E., Rius, B., González-Périz, A., López-Vicario, C., Morán-Salvador, E., Martínez-Clemente, M., Arroyo, V., & Clària, J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100225 · Cited by 412
Serhan, C. N., Jain, A., Marleau, S., Clish, C., Kantarci, A., Behbehani, B., Colgan, S. P., Stahl, G. L., Merched, A., Petasis, N. A., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6856 · Cited by 404
“15-LO to generate required lipid mediators/autacoids (16) that can”
BackgroundSelf-citationImmunomodulation by omega-3 fatty acids
Calder, P. C. (2007) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2007.10.015 · Cited by 402
Association of Cystic Fibrosis with Abnormalities in Fatty Acid Metabolism
Freedman, S. D., Blanco, P. G., Zaman, M. M., Shea, J. C., Ollero, M., Hopper, I. K., Weed, D. A., Gelrud, A., Regan, M. M., Laposata, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021218 · Cited by 395
Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease
Yates, C. M., Calder, P. C., & Ed Rainger, G. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.10.010 · Cited by 395
Natural resolution of inflammation
Freire, M. O., & Van Dyke, T. E. (2013) · Periodontology 2000 · doi:10.1111/prd.12034 · Cited by 388
A neuroscientist's guide to lipidomics
Piomelli, D., Astarita, G., & Rapaka, R. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2233 · Cited by 379
Resolvins and protectins in the termination program of acute inflammation
Ariel, A., & Serhan, C. N. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.02.007 · Cited by 381
Self-citationTransgenic mice rich in endogenous omega-3 fatty acids are protected from colitis
Hudert, C. A., Weylandt, K. H., Lu, Y., Wang, J., Hong, S., Dignass, A., Serhan, C. N., & Kang, J. X. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601280103 · Cited by 379
Self-citationFarooqui, A. A., Ong, W.-Y., & Horrocks, L. A. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.7 · Cited by 368
“Docosanoids include 10,17S-docosatrienes and 17S-resolvins (Hong et al., 2003; Marcheselli et al., 2003; Serhan et al., 2004).”
BackgroundNovel Lipid Mediators Promote Resolution of Acute Inflammation: Impact of Aspirin and Statins
Spite, M., & Serhan, C. N. (2010) · Circulation Research · doi:10.1161/circresaha.110.223883 · Cited by 365
Self-citationn -3 Fatty acids, inflammation and immunity: new mechanisms to explain old actions
Calder, P. C. (2013) · Proceedings of the Nutrition Society · doi:10.1017/s0029665113001031 · Cited by 364
“Resolvin synthesis is increased by feeding fish-oil rich diets to laboratory rodents((69)) and was shown to occur in fat-1 mice in which colitis had been induced((70)).”
Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis
Ilieva, E. V., Ayala, V., Jove, M., Dalfo, E., Cacabelos, D., Povedano, M., Bellmunt, M. J., Ferrer, I., Pamplona, R., & Portero-Otin, M. (2007) · Brain · doi:10.1093/brain/awm190 · Cited by 358
“Thus, while brain cortex could produce n-3-derived antiinflammatory resolvins and docosatrienes (Hong et al., 2003), spinal cord neurons would have decreased DHA availability due to increased lipoxidative consumption.”
BackgroundProtectin D1 Is Generated in Asthma and Dampens Airway Inflammation and Hyperresponsiveness
Levy, B. D., Kohli, P., Gotlinger, K., Haworth, O., Hong, S., Kazani, S., Israel, E., Haley, K. J., & Serhan, C. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.496 · Cited by 359
“PD1 promotes T Lymph apoptosis in vitro (18), and PD1 also carries systemic and topical anti-inflammatory actions for PMNs in vivo (3, 17).”
BackgroundMethodInfluentialSelf-citationHorrocks, L. A., & Farooqui, A. A. (2004) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.12.011 · Cited by 356
Miles, E. A., & Calder, P. C. (2012) · British Journal of Nutrition · doi:10.1017/s0007114512001560 · Cited by 352
Serhan, C. N., Arita, M., Hong, S., & Gotlinger, K. (2004) · Lipids · doi:10.1007/s11745-004-1339-7 · Cited by 349
“RvD2 Human whole blood (13) AT-RvD5 Murine inflammatory exudates (12) RvD4 Human whole blood ( 13 ) AT-RvD6 Murine inflammatory exudates (12) RvD5 Human whole blood glial cells (13) a AT denotes the aspirin-triggered R epimer; RvE1, resolvin E1; RvD1‐RvD6, resolvin D1‐D6.”
BackgroundMethodInfluentialSelf-citationEmerging roles of resolvins in the resolution of inflammation and pain
Ji, R.-R., Xu, Z.-Z., Strichartz, G., & Serhan, C. N. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.08.005 · Cited by 344
Self-citationDefective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway
Karp, C. L., Flick, L. M., Park, K. W., Softic, S., Greer, T. M., Keledjian, R., Yang, R., Uddin, J., Guggino, W. B., Atabani, S. F., et al. (2004) · Nature Immunology · doi:10.1038/ni1056 · Cited by 344
“A class of anti-inflammatory lipid mediators called 'resolvins', sharing many of the biological activities of lipoxins, are generated from ω-3 fatty acid”
BackgroundParrish, C. C. (2013) · ISRN Oceanography · doi:10.5402/2013/604045 · Cited by 336
Are all n-3 polyunsaturated fatty acids created equal?
Anderson, B. M., & Ma, D. W. (2009) · Lipids in Health and Disease · doi:10.1186/1476-511x-8-33 · Cited by 334
Resolvin D Series and Protectin D1 Mitigate Acute Kidney Injury
Duffield, J. S., Hong, S., Vaidya, V. S., Lu, Y., Fredman, G., Serhan, C. N., & Bonventre, J. V. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.5902 · Cited by 334
“RvDs and 17S-hydroxy-DHA (HDHA) were generated using DHA (Cayman Chemical) and 15-lipoxygenase (24, 30, 31).”
BackgroundMethodInfluentialSelf-citationOld and new generation lipid mediators in acute inflammation and resolution
Stables, M. J., & Gilroy, D. W. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.07.005 · Cited by 334
Resolution phase lipid mediators of inflammation: agonists of resolution
Serhan, C. N., & Chiang, N. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.05.012 · Cited by 331
Self-citationPolyunsaturated fatty acids and inflammation
Calder, P. C. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330423 · Cited by 327
Chiang, N., & Serhan, C. N. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.03.005 · Cited by 324
“CNS coined the first of these new mediators “resolvins”, indicating their potent bioactions and biosynthetic origins as in the resolution phase interaction products that function in catabasis to return the host tissues from leukocyte defensive position with microbial invaders to normal functions (Serhan et al., 2000,…”
BackgroundInfluentialSelf-citationEssential fatty acids in aquatic food webs
Parrish, C. C. (2009) · Lipids in Aquatic Ecosystems · doi:10.1007/978-0-387-89366-2_13 · Cited by 299
Serhan, C. N., Gotlinger, K., Hong, S., & Arita, M. (2004) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2004.03.005 · Cited by 310
Self-citationNeurological Benefits of Omega-3 Fatty Acids
Dyall, S. C., & Michael-Titus, A. T. (2008) · NeuroMolecular Medicine · doi:10.1007/s12017-008-8036-z · Cited by 311
Stepwise engineering to produce high yields of very long-chain polyunsaturated fatty acids in plants
Wu, G., Truksa, M., Datla, N., Vrinten, P., Bauer, J., Zank, T., Cirpus, P., Heinz, E., & Qiu, X. (2005) · Nature Biotechnology · doi:10.1038/nbt1107 · Cited by 310
“dtd" [ ]> Very long chain polyunsaturated fatty acids (VLCPUFAs) such as arachidonic acid (AA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are valuable commodities that provide important human health benefit”
BackgroundGronert, K., Maheshwari, N., Khan, N., Hassan, I. R., Dunn, M., & Laniado Schwartzman, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410638200 · Cited by 310
Self-citationOmega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer
Cockbain, A. J., Toogood, G. J., & Hull, M. A. (2012) · Gut · doi:10.1136/gut.2010.233718 · Cited by 305
Nutritional modulation of cognitive function and mental health
Parletta, N., Milte, C. M., & Meyer, B. J. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.01.002 · Cited by 302
Resolution of Acute Inflammation in the Lung
Levy, B. D., & Serhan, C. N. (2014) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021113-170408 · Cited by 298
Self-citation
Metadata
- Authors
- Hong, S., Gronert, K., Devchand, P. R., Moussignac, R.-L., & Serhan, C. N.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Serhan, Charles N.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-04
- Volume
- 278
- Issue
- 17
- Pages
- 14677-14687
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2082649626
- Cited by
- 1,000
- References
- 53
- Citations by year
- 2026: 15 · 2025: 21 · 2024: 24 · 2023: 32 · 2022: 24 · 2021: 42 · 2020: 36 · 2019: 51 · 2018: 44 · 2017: 43 · 2016: 40 · 2015: 59 · 2014: 66 · 2013: 63 · 2012: 48
- FWCI
- 34.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6388 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Institute of General Medical Sciences (GM 38765)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK60583, K01DK060583)
- National Institute of Dental and Craniofacial Research (P01 DE 13499, P01DE013499)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Keywords
- docosahexaenoic acid, docosanoids, omega-3 fatty acids, leukocyte infiltration, glial cells, cytokine production, inflammation resolution, epoxide intermediate, lipidomics, brain, leukocytes, leukotriene biosynthesis
- MeSH terms
- Animals, Blood, Brain, Chemotaxis, Leukocyte, Chromatography, High Pressure Liquid, Docosahexaenoic Acids, Fatty Acids, Unsaturated, Humans, Inflammation, Leukocytes, Neuroglia, Mass Spectrometry, Tumor Necrosis Factor-alpha, Cytokines, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.